The Absolute Bioavailability and Metabolic Disposition of the Novel Antimigraine Compound Zolmitriptan (311C90)
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1997.00614.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 1997
Authors
Publisher
Wiley